Dipyridamole and Naftifine hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Dipyridamole and Naftifine hydrochloride together.
The phase IV clinical study analyzes what interactions people who take Dipyridamole and Naftifine hydrochloride have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Dipyridamole and Naftifine hydrochloride together, and have interactions are studied.
What is Dipyridamole?
Dipyridamole has active ingredients of dipyridamole. eHealthMe is studying from 5,532 Dipyridamole users for its effectiveness, alternative drugs and more.
What is Naftifine hydrochloride?
Naftifine hydrochloride has active ingredients of naftifine hydrochloride. eHealthMe is studying from 30 Naftifine hydrochloride users for its effectiveness, alternative drugs and more.
Number of Dipyridamole and Naftifine hydrochloride reports submitted per year:
Common Dipyridamole and Naftifine Hydrochloride drug interactions by gender *:
female:
n/a
male:
- Pneumonia
- Pneumothorax
- Respiratory failure
- Thrombocytopenia
- Acinetobacter test positive
- Acne
- Pharyngitis
- Urine protein/creatinine ratio increased
Common Dipyridamole and Naftifine Hydrochloride drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Pneumonia
- Pneumothorax
- Respiratory failure
- Thrombocytopenia
- Acinetobacter test positive
- Acne
- Pharyngitis
- Urine protein/creatinine ratio increased
40-49:
n/a
50-59:
n/a
60+:
n/a
* Approximation only. Some reports may have incomplete information.
Do you take Dipyridamole and Naftifine hydrochloride?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Dipyridamole (5,532 reports)
- Naftifine hydrochloride (30 reports)
Browse all drug interactions of Dipyridamole and Naftifine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Dipyridamole side effects:
- Hypotension (abnormally low blood pressure): 642 reports
- Pain: 570 reports
- Constipation: 488 reports
Browse all side effects of Dipyridamole:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Dipyridamole interactions:
- Dipyridamole and Aspirin: 1,668 reports
- Dipyridamole and Furosemide: 1,001 reports
- Dipyridamole and Omeprazole: 918 reports
- Dipyridamole and Simvastatin: 763 reports
- Dipyridamole and Amlodipine: 728 reports
- Dipyridamole and Lactulose: 564 reports
- Dipyridamole and Acetylsalicylic acid: 560 reports
- Dipyridamole and Morphine: 550 reports
- Dipyridamole and Carbamazepine: 542 reports
- Dipyridamole and Oxazepam: 513 reports
Browse all interactions between Dipyridamole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dipyridamole and naftifine hydrochloride (the active ingredients of Dipyridamole and Naftifine hydrochloride, respectively), and Dipyridamole and Naftifine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Dipyridamole and Naftifine hydrochloride.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Enablex and Tooth Abscess - 22 seconds ago
- Posaconazole and Enlarged Prostate - 29 seconds ago
- Movantik and Lenvima drug interaction - 31 seconds ago
- Metformin and Bruxism - 33 seconds ago
- Ondansetron and Hyperemesis Gravidarum - 33 seconds ago
- Trintellix and Progressive Multifocal Leukoencephalopathy - 47 seconds ago
- Inlyta and Blood Creatinine Increased - 47 seconds ago
- Effexor and Lichen Sclerosus - 54 seconds ago
- Benadryl and Renal Ischaemia - 54 seconds ago
- Buprenex and Questran Light drug interaction - 55 seconds ago